What is Verastem Oncology's focus?

Verastem Oncology is a biopharmaceutical company focused on exploring the unexplored to give patients diagnosed with cancer better options, particularly those with RAS pathway-driven cancers.

What are Verastem Oncology's lead drug candidates?

Verastem Oncology's lead drug candidates are avutometinib (a RAF/MEK clamp) and defactinib (a FAK inhibitor), which are being evaluated in clinical trials as potential RAS-targeted treatment combinations.

What is Verastem Oncology's approach to developing new treatments?

Verastem Oncology is driven to develop treatments that give patients more choices and the possibility of better outcomes. The company is committed to pursuing paths that haven't been fully explored to deliver better options for patients, particularly those with RAS pathway-driven cancers.

How can patients and caregivers learn more about Verastem Oncology's clinical trials?

Patients and caregivers can find information about Verastem Oncology's clinical trials on the company's website or by contacting the company's medical information request team.

Voyager DB

Deep data on millions of local businesses, with verified decision-makers to reveal.

Contact Research

Hand-built prospect lists from human researchers, delivered in 24 hours.

People Search

Find owners and decision-makers by job title, seniority and department.

Chrome Extension

Coldlytics in your browser - prospect any business as you browse the web.

Integrations

Instantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

Voyager DBDeep data on millions of local businesses, with verified decision-makers to reveal.Contact ResearchHand-built prospect lists from human researchers, delivered in 24 hours.People SearchFind owners and decision-makers by job title, seniority and department.Chrome ExtensionColdlytics in your browser - prospect any business as you browse the web.IntegrationsInstantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

PricingPricing AgenciesAgencies BlogBlog

LoginLogin

Verastem Oncology

$22.0M revenue • 120 employees • 117 Kendrick St #500, Needham, MA, 02494, United States

Last Updated Aug 3, 2025

Own this business? Claim & update this listing →

Company Overview

Company Name

Verastem Oncology

Address

117 Kendrick St #500, Needham, MA, 02494, United States

Website

verastem.com

Phone

(781) 292-4200

Approx. Annual Revenue

$22.0M

Employees

120

Established

2010

Google Reviews

5.0 (2 reviews)

About Verastem Oncology

Verastem Oncology is a biopharmaceutical company focused on developing treatments for patients with cancer, particularly those with mutations in the RAS family of genes. The company's pipeline includes the investigational drugs avutometinib and defactinib, which are being explored in clinical trials for their potential to improve outcomes for patients with difficult-to-treat cancers.

Business Profile

Read from the Verastem Oncology website on Oct 17, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed): 8/10 · Current copyright 2026; Detailed pipeline and careers pages